Ginkgo Biloba: Memory Evidence and Safety

Preventing dementia, improving a test score, helping someone carry out everyday tasks and reducing a subjective memory complaint are not interchangeable goals. A claim can sound impressive while switching from one of these outcomes to another. Check which was actually measured.^{See reference 2,See reference 3}

Ginkgo products usually contain leaf extract. Studies of a characterized extract do not automatically apply to every powder, tea, seed preparation or multi-ingredient “memory” supplement. The plant name alone is not a complete description of an intervention.^{See reference 1,See reference 2,See reference 4}

The Ginkgo Evaluation of Memory trial randomized 3,069 people aged 75 or older, with normal cognition or mild cognitive impairment. It compared a standardized ginkgo extract at 120 mg twice daily with placebo, with a median follow-up of 6.1 years.^{See reference 2}

Dementia developed in 277 people assigned to ginkgo and 246 assigned to placebo. The hazard ratio was 1.12, with a 95% confidence interval of 0.94 to 1.33. The study did not demonstrate prevention. These results are not proof that ginkgo caused more dementia; the interval includes no difference.^{See reference 2}

The studied 240 mg total daily amount identifies that intervention. It does not become a recommended preventive dose when the trial did not show prevention, and the findings should not be generalized to every age group or product.^{See reference 2}

Cochrane included 82 studies with 10,613 participants and searched through November 2024. Its results differed by diagnosis. For dementia, possible benefits were mainly assessed around six months; study limitations and disagreement reduced confidence. Longer-term symptom benefit remains uncertain.^{See reference 3}

A possible symptom benefit in someone already diagnosed with dementia does not show that the disease was prevented, reversed or slowed. Treatment decisions require the person’s qualified care team and consideration of the whole clinical situation.^{See reference 2,See reference 3}

Ginkgo leaf extract can cause headache, dizziness and gastrointestinal symptoms. NCCIH warns that it may increase bleeding risk in people taking anticoagulants such as warfarin and may interact with other medicines. Bring the complete product and medicine list to a clinician or pharmacist.^{See reference 1}

Ginkgo may be unsafe during pregnancy, and safety during breastfeeding is poorly understood. Fresh seeds are toxic, and serious adverse effects have also been reported with roasted seeds or crude plant material. Seed preparations are not substitutes for the leaf extracts used in clinical research.^{See reference 1}

The 2026 review found little or no difference in overall adverse events between ginkgo and placebo in some diagnosed groups over the studied periods. This does not establish safety for every medicine combination, product or population.^{See reference 3}

Trials answer questions about people who met their entry criteria and about the intervention they received. For example, the GEM study used a specified extract and enrolled older volunteers under a research protocol. A shop product taken with a different medicine list is a new situation.^{See reference 2,See reference 4}

Look for the exact leaf extract, amount, other ingredients and any recognized quality verification. A product may be checked for composition or contamination without having been shown to improve memory. “Standardized” on a label is not an independent proof of benefit.^{See reference 4}

Product rules vary by country. NCCIH notes that U.S. dietary supplements do not receive the same premarket approval as drugs. That U.S. example is not a statement that every product worldwide has the same regulatory status.^{See reference 4}